| Literature DB >> 29356419 |
Ping Zhou1, Heng Zhao1, Quan Wang1, Zhiguo Zhou1, Jing Wang1, Guang Deng1, Xiyou Wang1, Qian Liu2, Hong Yang1, Shiping Yang1.
Abstract
Magnetic nanoparticles have gained much interest for theranostics benefited from their intrinsic integration of imaging and therapeutic abilities. Herein, c(RGDyK) peptide PEGylated Fe@Fe3 O4 nanoparticles (RGD-PEG-MNPs) are developed for photoacoustic (PA)-enabled self-guidance in tumor-targeting magnetic hyperthermia therapy in vivo. In the αv β3 -positive U87MG glioblastoma xenograft model, the PA signal of RGD-PEG-MNPs reaches its maximum in the tumor at 6 h after intravenous administration. This signal is enhanced by 2.2-folds compared to that of the preinjection and is also 2.2 times higher than that in the blocking group. It demonstrates the excellent targeting property of RGD-PEG-MNPs. With the guidance of the PA, an effective magnetic hyperthermia to tumor is achieved using RGD-PEG-MNPs.Entities:
Keywords: Fe@Fe3O4 nanoparticles; PA imaging; in vivo theranostics; magnetic hyperthermia
Mesh:
Substances:
Year: 2018 PMID: 29356419 DOI: 10.1002/adhm.201701201
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933